We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We may also share information about your use of our site with our social media, advertising and analytics partners. Read more about our Privacy Policy.

I got it!

Global Orphan Drugs And Rare Diseases Summit

Curtis & Wyss Group is pleased to invite you to the Global Orphan Drugs and Rare Diseases Summit scheduled for March 2 – 3, 2017 in Barcelona.

This event will bring together the full range of stakeholders and influencers in the orphan drug and rare disease sector, from the pharma and biotechs to patient advocates and representatives from payers to review recent developments in the orphan drug and rare diseases industry, to learn and discuss the most pressing topics, benchmark best practices with their peers and discover the future of orphan drug research, development and manufacture.

The Summit will be focusing on the strategic and commercial aspects of bringing new treatments to patients who suffer from rare diseases.

Our experts will be leading discussions covering how payers, pharmaceutical, biotech, patient organisations and academia are structuring to participate in and leverage the growing orphan drugs and rare diseases market.

It is an honor and privilege to invite you to participate in this Summit. We look forward to welcome you in Barcelona upcoming March!

 

Key Practical Learning Points of the Summit:

  • Drug Development and Market Challenges
  • Innovative strategies to incorporate the patient perspective and accelerate orphan drug development
  • Pricing, Reimbursement and Market Access Challenges for Advanced Therapy Medicinal Product & Orphan Drugs in the EU
  • Accelerating Commercialization of Rare Disease Treatments
  • Regulatory Pathway for Rare Disease treatments

Why should you be there?

  • Develop key relationships and meet with 450+ potential customers who need to find solutions to challenges around the commercial, regulatory and scientific issues in orphan drugs
  • Discuss how to better distribute your products and gain market access
  • Learn about key strategies and collaborations to accelerate rare disease clinical drug development
  • Enhance your knowledge on the role of patient organizations in promoting drug development for their disease
  • Interact and connect with leading companies in Orphan Drug and Rare Diseases industry

Who should attend?

  • CROs
  • CMOs
  • Market Access Consultancies
  • Regulatory Affairs Consultancies
  • Big Pharma and Biotech
  • Platform Technology Providers
  • OEM / Equipment Providers
  • Academia
  • Non-Profit Organisations

When

2 March 2017 @ 08:30 am

3 March 2017 @ 05:00 pm

Duration: 1 days, 8 hours

Where

Barcelona

Barcelona, Spain

13000 Barcelona

Spain

Organised by

Curtis Wyss (view profile)

Similar Events in Health

Annual Cardiology Conference

United States, 31 August 2017

Rapid and conventional micro methods seminar

United Kingdom, 8 June 2017

Health Economics for Non-Health-Economists

Belgium, 14 December 2017

Similar Webinars in Health

Recent Publications in Health

Sustainable Access to Innovative Therapies

Policy Recommendation, beuc.eu , May 2017

Recent Videos in Health

Hand Hygiene Day 2017

Health, 6 May 2017

Recent News in Health

Webinar: scientific aspects to consider when preparing a #NovelFood application https://t.co/sM2G6GKJvk https://t.co/fL7yn1PPab

@EFSA_EU - 26 May 2017 16:30

.@EU_IPO Executive Director shares his story on the #EU as a living project #EUAgencies #EU60… https://t.co/7R3CR2hPxd

@EFSA_EU - 26 May 2017 14:30

BBC's Emily Kasriel: The @bbcmediaaction #SoiCanBreathe series on #AirPollution was produced in 29 languages #WHA70 https://t.co/Y6kE56cEWz

@WHO_Europe - 26 May 2017 14:01

Dr Chan: Seven of the Sustainable Development Goals are connected to environmental risks. #EnvironmentalHealth… https://t.co/VZE1QludWO

@WHO_Europe - 26 May 2017 13:07

Dr Chan: The world is losing the capacity to keep human lives in good health #EnvironmentalHealth https://t.co/HU1lLzpSDH

@WHO_Europe - 26 May 2017 13:07